AzTrials
AzTrials

AppendicitisLOCATNCT01925014

Low vs. Standard Dose CT for Appendicitis Trial

A study testing Diagnostic CT with low-dose radiation and Diagnostic CT with standard-dose radiation in people with Appendicitis, run by Kyoung Ho Lee, MD at 20 sites in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To determine whether low-dose (LD) CT is noninferior to standard-dose (SD) computed tomography (CT) as the first-line imaging test in adolescents and young adults in regard to negative appendectomy rate (NAR). Read more about this study

Who is it for?
Ages 15 to 44 years
Conditions the study is for
Appendicitis
What is being tested?
Diagnostic CT with low-dose radiation and Diagnostic CT with standard-dose radiation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3,074 participants
Where
20 sitesSouth Korea
Study dates
Dec 2013to Feb 2017
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 44 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Emergency department visit with suspected symptoms and signs of acute appendicitis
  • Intravenous contrast-enhanced computed tomography examination requested due to suspicion of appendicitis
  • Willing to provide telephone or cell phone numbers for follow-up
  • Signed informed consent provided prior to study entry

Who cannot join

  • Prior cross-sectional imaging tests to evaluate the presenting symptoms and signs
  • Prior history of surgical removal of the appendix

Trial locations and contacts

20 sites in 1 country.

20 sites in 1 country

South Korea20 sites
  • Korea University Ansan Hospital

    Ansan, Gyeonggi-do, 425-707

  • Hallym University Sacred Heart Hospital

    Anyang-si, Gyeonggi-do, 431-070

  • Soonchunhyang University Bucheon Hospital

    Bucheon-si, Gyeonggi-do, 420-767

  • Kangwon National University Hospital

    Chuncheon, Gangwon-do, 200-722

  • Keimyung University Dongsan Medical Center

    Daegu, 700-712

  • Chonnam National University Hospital

    Gwangju, 501-757

  • Wonkwang University School of Medicine & Hospital

    Iksan, 570-711

  • Gachon University Gil Medical Center

    Incheon, 405-760

  • Jeju National University Hospital

    Jeju City, 690-767

  • Wonkwang University Sanbon Hospital

    Sanbon, Gyeonggi-do, 435-040

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, 463-707

  • Daejin Medical Center, Bundang Jesaeng General Hospital

    Seongnam-si, Gyeonggi-do, 463-774

  • Seoul National University Hospital

    Seoul, 110-744

  • Kangbuk Samsung Hospital

    Seoul, 110-746

  • Severance Hospital

    Seoul, 120-752

  • The Catholic University of Korea, College of Medicine, Seoul St. Mary's Hospital

    Seoul, 137-701

  • Soonchunhyang University Seoul Hospital

    Seoul, 140-887

  • Hallym University Kangnam Sacred Heart Hospital

    Seoul, 150-950

  • Korea University Guro Hospital

    Seoul, 152-703

  • Chung-Ang University Hospital

    Seoul, 156-755

Other trials in South Korea

About this study

Official title: A Multi-institutional Trial Comparing Clinical Outcomes Following Low- vs. Standard-dose Abdominal CT as the First-line Imaging Test in Adolescents and Young Adults With Suspected Acute Appendicitis

To determine whether low-dose (LD) CT is noninferior to standard-dose (SD) computed tomography (CT) as the first-line imaging test in adolescents and young adults in regard to negative appendectomy rate (NAR).

Read the detailed description
  • Acute appendicitis is a very common disease. Many patients are adolescents or young adults.
  • CT is the current standard imaging test for the diagnosis of appendicitis.
  • In recent years, the awareness of carcinogenic risk associated with CT radiation has increased.
  • According to a recent single-institutional randomized controlled trial, LD CT (employing a quarter of standard radiation dose) was found to be noninferior to SD CT with respect to NARs in adolescents and young adults with suspected appendicitis.
  • However, LD CT is not yet widely accepted.
  • To establish LD CT as the first-line imaging test, a multi-institutional study is needed to confirm the generalizability of the prior single-institutional study.
Conditions
Appendicitis
Being tested
Diagnostic CT with low-dose radiation, Diagnostic CT with standard-dose radiation
Keywords
Appendectomy, Appendicitis, False Positive Reactions, Humans, Radiation Dosage, Tomography, X-Ray Computed, Young Adult
Medical subject headings
Appendicitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diagnostic CT with low-dose radiationDiagnostic test

    Also called Low-dose CT

    Effective dose is aimed at approximately 2 millisievert (mSv) in an average patient.

  • Diagnostic CT with standard-dose radiationDiagnostic test

    Also called Standard-dose CT

    Effective dose is aimed at approximately 8 millisievert (or less) in an average patient.

Study groups in NCT01925014
Study groupRoleWhat they receive
Low-dose CTExperimentalDiagnostic CT with low-dose radiation
Receives: Diagnostic Test: Diagnostic CT with low-dose radiation
Standard-dose CTActive comparatorDiagnostic CT with standard-dose radiation
Receives: Diagnostic Test: Diagnostic CT with standard-dose radiation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Negative Appendectomy Rate

    Negative appendectomy rate was defined as the percentage of negative (unnecessary) appendectomies among all non-incidental appendectomies. As a secondary analysis, negative appendectomy rate in an alternative definition was calculated by excluding cases with appendiceal neoplasms without superimposed appendicitis, as appendectomy would be clinically necessary in such patients. Any surgery performed for the treatment of presumed appendicitis was counted as non-incidental appendectomy, even though the surgical procedures were more extensive than simple appendectomy (e.g., ileocectomy).

    Measured: 1 week after surgery

Secondary outcomes (14)
  1. Appendiceal Perforation Rate

    The percentage of perforated appendicitis among confirmed appendicitis cases.

    Measured: 1 week after surgery

  2. Number of Appendectomies

    Appendectomy rate. The percentage of appendectomies among all randomized cases.

    Measured: 3 months after CT

  3. Number of Negative Appendectomies

    The percentage of negative appendectomies among all randomized cases. In January, 2016, when more than 2000 patients were enrolled, the data and safety monitoring board noted a between-group imbalance in the number of appendectomies. Because of the concern that such an imbalance might potentially jeopardize the comparability for the prespecified endpoints, the study protocol was amended to adopt the following additional secondary endpoints, which were assessed among all randomly assigned patients: the number of appendectomies, number of negative appendectomies, prevalence of perforated appendicitis, and prevalence of non-perforated appendicitis.

    Measured: 1 week after surgery

  4. Prevalence of Perforated Appendicitis

    The percentage (i.e., prevalence) of perforated appendicitis among all randomized cases. In January, 2016, when more than 2000 patients were enrolled, the data and safety monitoring board noted a between-group imbalance in the number of appendectomies. Because of the concern that such an imbalance might potentially jeopardize the comparability for the prespecified endpoints, the study protocol was amended to adopt the following additional secondary endpoints, which were assessed among all randomly assigned patients: the number of appendectomies, number of negative appendectomies, prevalence of perforated appendicitis, and prevalence of non-perforated appendicitis.

    Measured: 1 week after surgery

  5. Prevalence of Non-perforated Appendicitis

    The percentage (i.e., prevalence) of non-perforated appendicitis among all randomized cases. In January, 2016, when more than 2000 patients were enrolled, the data and safety monitoring board noted a between-group imbalance in the number of appendectomies. Because of the concern that such an imbalance might potentially jeopardize the comparability for the prespecified endpoints, the study protocol was amended to adopt the following additional secondary endpoints, which were assessed among all randomly assigned patients: the number of appendectomies, number of negative appendectomies, prevalence of perforated appendicitis, and prevalence of non-perforated appendicitis.

    Measured: 1 week after surgery

  6. Need for Additional Imaging Test(s)

    The proportion of patients requiring additional imaging test(s) in order to diagnose or rule out appendicitis.

    Measured: 1 week after CT

  7. Delay in Patient Disposition

    • The interval from CT acquisition to appendectomy in patients undergoing appendectomy. Interval appendectomies following percutaneous abscess drainage and/or medical treatment were not included in this analysis.
    • The interval from CT acquisition to hospital discharge in patients not undergoing surgery.

    Measured: 3 months after CT

  8. Length of Hospital Stay Associated With Appendectomy

    The interval from CT acquisition to hospital discharge after appendectomy.

    Measured: 3 months after CT

  9. Diagnostic Performance of CT Reports - AUC

    • Area under the receiver-operating-characteristic curve (AUC).

    Measured: 3 months after CT

  10. Diagnostic Performance of CT Reports - Sensitivity and Specificity

    • Diagnostic sensitivity and specificity: the 5-grade likelihood scores for appendicitis were collapsed into binary responses with a decision threshold of a score ≥ 3 as positive for the diagnosis.
    • Sensitivity is a proportion of the positive test among the patient confirmed as having appendicitis.
    • Specificity is a proportion of the negative test among the patient confirmed as not having appendicitis.

    Measured: 3 months after CT

  11. Diagnostic Confidence in Diagnosing and Ruling Out Appendicitis: Likelihood Score for Appendicitis

    • Likelihood score for appendicitis in patients confirmed as having appendicitis.
    • Likelihood score for appendicitis in patients confirmed as not having appendicitis.

    Grade 1 denotes appendicitis definitely absent; grade 2, appendicitis probably absent; grade 3, indeterminate for the presence of appendicitis; grade 4, appendicitis probably present; and grade 5, appendicitis definitely present.

    Measured: 3 months after CT

  12. Diagnostic Confidence in Diagnosing and Ruling Out Appendicitis: Indeterminate Interpretation (Grade 3)

    The frequency of indeterminate CT interpretation (grade 3). Grade 1 denotes appendicitis definitely absent; grade 2, appendicitis probably absent; grade 3, indeterminate for the presence of appendicitis; grade 4, appendicitis probably present; and grade 5, appendicitis definitely present.

    Measured: 3 months after CT

  13. Diagnostic Confidence in Ruling Out Appendicitis: Normal Appendix Visualization

    The frequency of normal appendix visualization at CT. Grade 0 denotes appendix not identified; grade 1, unsure or partly visualized; and grade 2, clearly and entirely visualized.

    Measured: 3 months after CT

  14. Diagnosis of Appendiceal Perforation at CT

    • Diagnostic sensitivity: the number of correct detections of the perforation divided by the number of cases of perforated appendicitis.
    • Diagnostic specificity: the number of correct ruling out the perforation divided by the number of cases of appendicitis without perforation.

    Measured: 3 months after CT

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2013 (estimated)
  2. Study startDec 2013
  3. Primary completionDec 2016
  4. Study completionFeb 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
3,074 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01925014
Sponsor's protocol ID
LOCAT
Acronym
LOCAT
Status last verified
Aug 2018
First submitted
15 Aug 2013
Last updated
31 Jan 2019
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The LOCAT Group has an active standpoint for sharing the LOCAT data, which is in line with the proposal from the International Committee of Medical Journal Editors. The LOCAT Group will share de-identified individual-participant data underlying the main LOCAT results no later than 6 months after the publication of the results. The data will be kept in a publicly available website and freely available to anyone upon request.

Publications

  • Kim K, Kim YH, Kim SY, Kim S, Lee YJ, Kim KP, Lee HS, Ahn S, Kim T, Hwang SS, Song KJ, Kang SB, Kim DW, Park SH, Lee KH. Low-dose abdominal CT for evaluating suspected appendicitis. N Engl J Med. 2012 Apr 26;366(17):1596-605. doi: 10.1056/NEJMoa1110734.

    PubMed 22533576
  • Ahn S; LOCAT group. LOCAT (low-dose computed tomography for appendicitis trial) comparing clinical outcomes following low- vs standard-dose computed tomography as the first-line imaging test in adolescents and young adults with suspected acute appendicitis: study protocol for a randomized controlled trial. Trials. 2014 Jan 17;15:28. doi: 10.1186/1745-6215-15-28.

    PubMed 24438500
  • Ko Y, Choi JW, Kim DH, Lee KJ, Shin SS, Woo JY, Cho SW, Kim BS, Lee KH. Central image archiving and management system for multicenter clinical studies: lessons from low-dose CT for appendicitis trial. J Korean Soc Radiol. 2017 Mar 28;76(3):165-72. doi: 10.3348/jksr.2017.76.3.165.

  • Yang HK, Ko Y, Lee MH, Woo H, Ahn S, Kim B, Pickhardt PJ, Kim MS, Park SB, Lee KH; Low-Dose CT for Appendicitis Trial (LOCAT) Group. Initial Performance of Radiologists and Radiology Residents in Interpreting Low-Dose (2-mSv) Appendiceal CT. AJR Am J Roentgenol. 2015 Dec;205(6):W594-611. doi: 10.2214/AJR.15.14513.

    PubMed 26587949
  • Kim HY, Lee S, Kim DH, Ko Y, Park JH, Ko A, Jeong SM, Park SB, Lee KH; LOCAT Group. Conventional-Dose CT Versus 2-mSv CT for Right Colonic Diverticulitis as an Alternate Diagnosis of Appendicitis: Secondary Analysis of Large Pragmatic Randomized Trial Data. AJR Am J Roentgenol. 2021 Nov;217(5):1113-1121. doi: 10.2214/AJR.21.25584. Epub 2021 Apr 7.

    PubMed 33825498
  • LOCAT Group. Low-dose CT for the diagnosis of appendicitis in adolescents and young adults (LOCAT): a pragmatic, multicentre, randomised controlled non-inferiority trial. Lancet Gastroenterol Hepatol. 2017 Nov;2(11):793-804. doi: 10.1016/S2468-1253(17)30247-9. Epub 2017 Sep 12.

    PubMed 28919126

Questions about this trial

What is this clinical trial studying?

A study testing Diagnostic CT with low-dose radiation and Diagnostic CT with standard-dose radiation in people with Appendicitis, run by Kyoung Ho Lee, MD at 20 sites in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 20 sites in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 31 Jan 2019). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Negative Appendectomy Rate (time frame: 1 week after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01925014, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in